Literature DB >> 23965281

Chitosan-based siRNA delivery systems.

Héloïse Ragelle1, Gaëlle Vandermeulen1, Véronique Préat2.   

Abstract

Recently, chitosan has attracted significant attention in the formulation of small interfering RNA (siRNA). Because of its cationic nature, chitosan can easily complex siRNA, thus readily forming nanoparticles. Moreover, chitosan is biocompatible and biodegradable, which make it a good candidate for siRNA delivery in vivo. However, chitosan requires further development to achieve high efficiency. This review will describe the major barriers that impair the efficiency of the chitosan-based siRNA delivery systems, including the stability of the delivery system in biological fluids and endosomal escape. Several solutions to counteract these barriers have been developed and will be discussed. The parameters to consider for designing powerful delivery systems will be described, particularly the possibilities for grafting targeting ligands. Finally, optimized systems that allow in vivo therapeutic applications for both local and systemic delivery will be reviewed. This review will present recent improvements in chitosan-based siRNA delivery systems that overcome many of these system's previous pitfalls and pave the way to a new generation of siRNA delivery systems.
© 2013.

Keywords:  Chitosan; Delivery barriers; Ligand; Nanoparticles; RNA interference; siRNA

Mesh:

Substances:

Year:  2013        PMID: 23965281     DOI: 10.1016/j.jconrel.2013.08.005

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  43 in total

1.  SYBR Gold Fluorescence Quenching is a Sensitive Probe of Chitosan-microRNA Interactions.

Authors:  Beatriz Santos-Carballal; Musti J Swamy; Bruno M Moerschbacher; Francisco M Goycoolea
Journal:  J Fluoresc       Date:  2015-10-28       Impact factor: 2.217

Review 2.  Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.

Authors:  Nazila Kamaly; Basit Yameen; Jun Wu; Omid C Farokhzad
Journal:  Chem Rev       Date:  2016-02-08       Impact factor: 60.622

Review 3.  Nano-enabled delivery of diverse payloads across complex biological barriers.

Authors:  Kathleen A Ross; Timothy M Brenza; Andrea M Binnebose; Yashdeep Phanse; Anumantha G Kanthasamy; Howard E Gendelman; Aliasger K Salem; Lyric C Bartholomay; Bryan H Bellaire; Balaji Narasimhan
Journal:  J Control Release       Date:  2015-08-24       Impact factor: 9.776

4.  Chitosan-based hybrid nanocomplex for siRNA delivery and its application for cancer therapy.

Authors:  Min-Hyo Ki; Ji-Eon Kim; Young-Nam Lee; Sang Myoung Noh; Sung-Won An; Hyun-Jong Cho; Dae-Duk Kim
Journal:  Pharm Res       Date:  2014-05-24       Impact factor: 4.200

5.  Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.

Authors:  Sathish Dyawanapelly; Uday Koli; Vimisha Dharamdasani; Ratnesh Jain; Prajakta Dandekar
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

6.  Effectiveness of Small Interfering RNA Delivery via Arginine-Rich Polyethylenimine-Based Polyplex in Metastatic and Doxorubicin-Resistant Breast Cancer Cells.

Authors:  Shan Lu; Viola B Morris; Vinod Labhasetwar
Journal:  J Pharmacol Exp Ther       Date:  2019-04-02       Impact factor: 4.030

7.  Chitosan-Mediated shRNA Knockdown of Cytosolic Alanine Aminotransferase Improves Hepatic Carbohydrate Metabolism.

Authors:  Juan D González; Jonás I Silva-Marrero; Isidoro Metón; Albert Caballero-Solares; Ivan Viegas; Felipe Fernández; Montserrat Miñarro; Anna Fàbregas; Josep R Ticó; John G Jones; Isabel V Baanante
Journal:  Mar Biotechnol (NY)       Date:  2016-02       Impact factor: 3.619

Review 8.  Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.

Authors:  Nishant S Gandhi; Rakesh K Tekade; Mahavir B Chougule
Journal:  J Control Release       Date:  2014-09-07       Impact factor: 9.776

Review 9.  Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy.

Authors:  Anish Babu; Ranganayaki Muralidharan; Narsireddy Amreddy; Meghna Mehta; Anupama Munshi; Rajagopal Ramesh
Journal:  IEEE Trans Nanobioscience       Date:  2016-12       Impact factor: 2.935

10.  Design, characterization, and intracellular trafficking of biofunctionalized chitosan nanomicelles.

Authors:  Weiyi Li; Giulia Suarato; Jillian M Cathcart; Paul R Sargunas; Yizhi Meng
Journal:  Biointerphases       Date:  2020-11-13       Impact factor: 2.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.